Clinical data suggests up to 50% of chronic pain patients may have at least one "unexpected" urine drug test result during their treatm...
For clinical directors and operations managers, administrative burdens are the primary constraint in high-volume drug testing environme...
Medication-Assisted Treatment (MAT) is a cornerstone of modern opioid use disorder (OUD) management. The data is clear: methadone can r...
Effective drug testing in a recovery setting is a delicate balance. You need a program that promotes accountability and ensures residen...
If you are managing a drug testing program in 2026, you already know that the "one-size-fits-all" corporate policy is completely obsole...
If you are evaluating workplace drug testing solutions in 2026, the landscape looks drastically different than it did just two y...
If you are managing a workplace testing program, running a clinical facility, or overseeing compliance, you already know that simply fi...
If you are evaluating your workplace drug testing policies in 2026, you are likely feeling a very specific type of administrative whipl...
If you are currently evaluating your organization's drug testing policy in 2026, you are likely wrestling with a fundamental shift in w...
Staring at a rapid drug test device waiting for a result is an inherently stressful experience. Whether you are an employer ensu...
The shift toward oral fluid testing is one of the most defining trends in workplace safety and clinical screening today. If you are ...
If you are managing a workplace testing program in 2026, you are likely feeling the tension between two competing priorities: the absol...
